Correction of Antidiuresis by Demeclocycline
- 30 October 1975
- journal article
- case report
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 293 (18) , 915-918
- https://doi.org/10.1056/nejm197510302931809
Abstract
ALL the signs and symptoms of the syndrome of inappropriate secretion of antidiuretic hormone result from excessive retention of water. Accordingly, adequate restriction of water and fluid intake prevents the hyponatremia and the associated clinical manifestations. Since the original description of the syndrome, severe fluid deprivation has been the only therapeutic approach in the chronic form.1 Unfortunately, this therapy causes much discomfort to the patient, and, when not followed, results in repeated and sometimes life-threatening episodes of water intoxication. Recently, lithium carbonate has been successfully used in a patient with the syndrome,2 but this drug is frequently associated with inconvenient . . .Keywords
This publication has 9 references indexed in Scilit:
- Lithium Inhibition of cAMP-Mediated Hormones: A CautionNew England Journal of Medicine, 1975
- Treatment of the Syndrome of Inappropriate Secretion of Antidiuretic Hormone with Lithium CarbonateNew England Journal of Medicine, 1975
- On the Mechanism of Lithium-Induced Diabetes Insipidus in Man and the RatJournal of Clinical Investigation, 1974
- Demeclocycline-Induced Nephrogenic Diabetes InsipidusAnnals of Internal Medicine, 1973
- Myocardial Irritability Associated with Lithium Carbonate TherapyNew England Journal of Medicine, 1972
- Nephrotoxicity of Demethylchlortetracycline HydrochlorideArchives of internal medicine (1960), 1967
- Nephrogenic Diabetes Insipidus Due to Demethylchlortetracycline HydrochlorideJAMA, 1965
- Metabolic Effects of TetracyclineAnnals of Internal Medicine, 1963
- Renal Disease and the Metabolic Effects of TetracyclineAnnals of Internal Medicine, 1963